ATE516802T1 - Verfahren zur modulierung der phototoxizität - Google Patents
Verfahren zur modulierung der phototoxizitätInfo
- Publication number
- ATE516802T1 ATE516802T1 AT03728425T AT03728425T ATE516802T1 AT E516802 T1 ATE516802 T1 AT E516802T1 AT 03728425 T AT03728425 T AT 03728425T AT 03728425 T AT03728425 T AT 03728425T AT E516802 T1 ATE516802 T1 AT E516802T1
- Authority
- AT
- Austria
- Prior art keywords
- modulating
- phototoxicity
- enhance
- methods
- ultraviolet light
- Prior art date
Links
- 206010034972 Photosensitivity reaction Diseases 0.000 title 1
- 208000007578 phototoxic dermatitis Diseases 0.000 title 1
- 231100000018 phototoxicity Toxicity 0.000 title 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 230000008832 photodamage Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Radiation-Therapy Devices (AREA)
- Photovoltaic Devices (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37403302P | 2002-04-19 | 2002-04-19 | |
PCT/US2003/011842 WO2003088909A2 (en) | 2002-04-19 | 2003-04-17 | Methods for modulating phototoxicity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE516802T1 true ATE516802T1 (de) | 2011-08-15 |
Family
ID=29251125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03728425T ATE516802T1 (de) | 2002-04-19 | 2003-04-17 | Verfahren zur modulierung der phototoxizität |
Country Status (17)
Country | Link |
---|---|
US (3) | US6992071B2 (de) |
EP (1) | EP1496891B1 (de) |
JP (2) | JP4527405B2 (de) |
CN (1) | CN1298321C (de) |
AT (1) | ATE516802T1 (de) |
AU (1) | AU2003234119B2 (de) |
CA (2) | CA2482320C (de) |
CY (1) | CY1112194T1 (de) |
DK (1) | DK1496891T3 (de) |
ES (1) | ES2367258T3 (de) |
HK (1) | HK1077761B (de) |
IL (2) | IL164560A0 (de) |
MX (1) | MXPA04010228A (de) |
NZ (1) | NZ535982A (de) |
PT (1) | PT1496891E (de) |
RU (1) | RU2301800C2 (de) |
WO (1) | WO2003088909A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04010228A (es) * | 2002-04-19 | 2005-06-08 | Univ Arizona | Metodos para modular la fotoxicidad. |
CA2716797A1 (en) * | 2008-03-10 | 2009-09-17 | Basf Se | Encapsulated phase change materials in seed coatings |
AU2010231598A1 (en) * | 2009-03-30 | 2011-11-10 | Shiseido Company, Ltd. | Composition for alleviating ultraviolet radiation-induced damage |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310461A (en) * | 1980-06-23 | 1982-01-12 | E. R. Squibb & Sons, Inc. | Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids |
US4902684A (en) * | 1988-06-20 | 1990-02-20 | E. R. Squibb & Sons, Inc. | Benzazepine and benzothiazepine derivatives |
US6309440B1 (en) * | 1998-08-25 | 2001-10-30 | Thomas T. Yamashita | Method and composition for promoting and controlling growth of plants |
US5208249A (en) * | 1992-08-20 | 1993-05-04 | Clintec Nutrition Co. | Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate |
JPH0797322A (ja) * | 1993-09-29 | 1995-04-11 | Shiseido Co Ltd | 一重項酸素消去剤 |
US5681554A (en) * | 1995-06-28 | 1997-10-28 | Cosmair, Inc. | Composition for treating hair and method for using the same |
US6013250A (en) * | 1995-06-28 | 2000-01-11 | L'oreal S. A. | Composition for treating hair against chemical and photo damage |
JP2961074B2 (ja) * | 1995-09-06 | 1999-10-12 | 明治製菓株式会社 | 光化学療法用の新生血管閉塞剤 |
JPH09249567A (ja) * | 1996-01-12 | 1997-09-22 | Otsuka Pharmaceut Co Ltd | 医薬組成物 |
ATE253885T1 (de) * | 1996-05-07 | 2003-11-15 | Eric F Bernstein | Topische verwendung von tempol zur vorbeugung der lichtalterung |
US20010056085A1 (en) * | 1996-07-09 | 2001-12-27 | Avner Ramu | Methods of using vesicant drug formulations |
CA2266412A1 (en) * | 1996-09-18 | 1998-03-26 | William J. Sarill | Compositions containing cobalamin and amino acids |
WO1998043976A1 (fr) * | 1997-03-31 | 1998-10-08 | Wakamoto Pharmaceutical Co., Ltd. | Derives de biphenyle et compositions medicinales |
US6103487A (en) * | 1997-08-27 | 2000-08-15 | Merck & Co., Inc. | Method of treating cancer |
FR2775595B1 (fr) * | 1998-03-09 | 2000-05-05 | Seppic Sa | Composition synergique comprenant un compose a structure lipoaminoacide et un extrait de menuphar |
JPH11255715A (ja) * | 1998-03-13 | 1999-09-21 | Kao Corp | N,n−ジ置換アニリン誘導体 |
US20020006418A1 (en) * | 1998-10-13 | 2002-01-17 | John Kung | Composition to enhance permeation of topical skin agents |
FR2792650B1 (fr) * | 1999-04-20 | 2003-02-28 | Oreal | Equivalent de peau agee, son procede de preparation et son utilisation |
KR20020023941A (ko) * | 1999-04-30 | 2002-03-29 | 오베르더 왈터 | 산화방지성 비타민 b6 유사체 |
WO2000066119A1 (en) * | 1999-05-05 | 2000-11-09 | Merck & Co., Inc. | Novel prolines as antimicrobial agents |
US20020006394A1 (en) * | 2000-02-11 | 2002-01-17 | Redmond Robert W. | Photochemical tissue bonding |
US6464992B2 (en) * | 2000-04-14 | 2002-10-15 | University Of Kentucky Research Foundation | Topical micronutrient delivery system and uses thereof |
US20030185864A1 (en) * | 2000-07-19 | 2003-10-02 | Asako Kobayashi | Preventives or remedies for atopic dermatitis |
JP2002128651A (ja) * | 2000-10-25 | 2002-05-09 | Kose Corp | 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤 |
WO2002062251A2 (en) * | 2001-02-05 | 2002-08-15 | Buchanan L Stephen | Multi-tapered dental files |
MXPA04010228A (es) * | 2002-04-19 | 2005-06-08 | Univ Arizona | Metodos para modular la fotoxicidad. |
DE102005000868A1 (de) * | 2004-10-15 | 2006-04-20 | Henkel Kgaa | Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren |
-
2003
- 2003-04-17 MX MXPA04010228A patent/MXPA04010228A/es active IP Right Grant
- 2003-04-17 JP JP2003585662A patent/JP4527405B2/ja not_active Expired - Fee Related
- 2003-04-17 NZ NZ535982A patent/NZ535982A/en not_active IP Right Cessation
- 2003-04-17 WO PCT/US2003/011842 patent/WO2003088909A2/en active Application Filing
- 2003-04-17 AU AU2003234119A patent/AU2003234119B2/en not_active Ceased
- 2003-04-17 PT PT03728425T patent/PT1496891E/pt unknown
- 2003-04-17 CA CA2482320A patent/CA2482320C/en not_active Expired - Fee Related
- 2003-04-17 RU RU2004133322/04A patent/RU2301800C2/ru not_active IP Right Cessation
- 2003-04-17 EP EP03728425A patent/EP1496891B1/de not_active Expired - Lifetime
- 2003-04-17 CA CA2668311A patent/CA2668311C/en not_active Expired - Fee Related
- 2003-04-17 US US10/418,629 patent/US6992071B2/en not_active Expired - Lifetime
- 2003-04-17 ES ES03728425T patent/ES2367258T3/es not_active Expired - Lifetime
- 2003-04-17 DK DK03728425.4T patent/DK1496891T3/da active
- 2003-04-17 AT AT03728425T patent/ATE516802T1/de active
- 2003-04-17 CN CNB038087766A patent/CN1298321C/zh not_active Expired - Fee Related
-
2004
- 2004-09-09 US US10/937,537 patent/US20050042188A1/en not_active Abandoned
- 2004-10-13 IL IL16456004A patent/IL164560A0/xx unknown
-
2005
- 2005-09-13 US US11/226,615 patent/US7226937B2/en not_active Expired - Lifetime
-
2006
- 2006-01-05 HK HK06100235.9A patent/HK1077761B/zh not_active IP Right Cessation
-
2010
- 2010-02-15 IL IL203968A patent/IL203968A/en active IP Right Grant
- 2010-04-28 JP JP2010103731A patent/JP5244150B2/ja not_active Expired - Lifetime
-
2011
- 2011-10-14 CY CY20111100977T patent/CY1112194T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE435209T1 (de) | Verfahren zur herstellung von montelukast-natrium | |
ATE425136T1 (de) | Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen | |
ATE469957T1 (de) | Verfahren zur herstellung von ölzusammensetzungen | |
DE602006021223D1 (de) | Verfahren zur identifizierung von trpv2-modulatoren | |
DE602006011457D1 (de) | Verfahren zur herstellung von 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholansäure | |
DE112004001806D2 (de) | Verfahren zur Selbstjustierenden Verkleinerung von Strukturen | |
DE602006010400D1 (de) | Olanzapin-analoga und verfahren zu ihrer verwendung | |
DE602004020895D1 (de) | Verfahren zur herstellung von kohlenstoffnanospulen | |
ATE455778T1 (de) | Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat | |
ATE405374T1 (de) | Verfahren zur herstellung von brillengläsern | |
ATE453619T1 (de) | Verfahren zur herstellung von hydroperoxiden | |
DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
ATE516802T1 (de) | Verfahren zur modulierung der phototoxizität | |
DE602004014264D1 (de) | Verfahren zur herstellung von olanzapin | |
ATA14432002A (de) | Verbessertes verfahren zur singlet sauerstoff oxidation von organischen substraten | |
ATA16992003A (de) | Verfahren zur qualitätssicherung von langholz | |
ATE397085T1 (de) | Verfahren zur reproduzierung von pleuromutilinen | |
ATE471941T1 (de) | Verfahren zur herstellung von thiazolopyrimidinen | |
ATE356128T1 (de) | Verfahren zur herstellung von tubulininhibitoren | |
ATE402948T1 (de) | Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält | |
ATE425163T1 (de) | Verfahren zur herstellung von chinuclidiniumcarbamatderivaten | |
ATE382035T1 (de) | Verfahren zur herstellung von n-substituierten phthalimiden | |
ATE477244T1 (de) | Verfahren zur herstellung von bengamide-derivaten | |
ATE468323T1 (de) | Verfahren zur hertellung von 2-cyan-3-hydroxy-n- (phenyl)but-2-enamiden | |
DE502004000843D1 (de) | Verfahren zur anodischen alkoxylierung von organischen verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1496891 Country of ref document: EP |